Original Literature | Model OverView |
---|---|
Publication
Title
The interferon-alpha/beta system in antiviral responses: a multimodal machineryof gene regulation by the IRF family of transcription factors.
Affiliation
Department of Immunology, Faculty of Medicine and Graduate School of Medicine,University of Tokyo, Hongo 7-3-1, Bunkyo-ku, 113-0033, Tokyo, Japan.tada@m.u-tokyo.ac.jp
Abstract
The efficient induction of interferons alpha and beta (IFN-alpha/beta) invirus-infected cells is central to the antiviral response of a host and isregulated mainly at the level of gene transcription. Once produced,IFN-alpha/beta transmit signals to the cell interior via a specific receptorcomplex to induce an antiviral response. Recently, the auto-amplificationmechanism of the IFN-alpha/beta system that follows viral infection has beenidentified. This mechanism is mediated by transcription factors of the IFNregulatory factor family and, in fact, may have evolved to render the systemmore robust in antiviral responses.
PMID
11790540
|
Entity
IFN-beta
--
G010228
cso30:c:mRNA
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m93217
10
infinite
0
TRANSFAC | G010228 |
--
NF-kappaB
--
MO000000058
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m14
10
infinite
0
TRANSPATH | MO000000058 |
--
c-Fos
--
MO000000279
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m221
10
infinite
0
InterPro | IPR002114 |
TRANSPATH | MO000000279 |
--
IFNalpha, IFNbeta
--
MO000038482
cso30:c:Protein
cso30:i:CC_CellComponent
--
--
csml-variable:Double
m16692
10
infinite
0
TRANSPATH | MO000038482 |
--
IRF-3{p}
--
MO000041456
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m19324
10
infinite
0
TRANSPATH | MO000041456 |
--
IRF-7{p}
--
MO000041457
cso30:c:Protein
cso30:i:CC_CellComponent
--
csml-variable:Double
m19325
10
infinite
0
TRANSPATH | MO000041457 |
--
--
e1
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane
--
--
--
csml-variable:Double
m1
0
infinite
0
--
--
e10
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytosol
--
--
--
csml-variable:Double
m10
0
infinite
0
--
unmethylated DNA
--
e11
cso30:c:Dna
cso30:i:CC_Extracellular
--
csml-variable:Double
m11
0
infinite
0
--
csml-variable:Double
m12
10
infinite
0
Affymetrix | 103634_at |
Ensembl | ENSMUSG00000002325 |
InterPro | IPR008984 |
MGD | MGI:107587 |
Proteome | HumanPSD/Isgf3g |
RefSeq | NM_008394 |
TRANSFAC | T05096 |
TRANSPATH | MO000031278 |
Unigene | Mm.2032 |
UniProt | Q61179 |
--
IFNAR1: IFNAR2: Jak1: Tyk2
--
e14
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
csml-variable:Double
m15
0
infinite
0
--
IFNAR1: IFNAR2: Jak1: Tyk2: IFNalpha,IFNbeta
--
e15
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m16
0
infinite
0
--
csml-variable:Double
m17
0
infinite
0
--
IFNAR1: IFNAR2: Jak1{activated}: Tyk2 {activated}: IFNalpha,IFNbeta
--
e17
cso30:c:Complex
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
csml-variable:Double
m18
0
infinite
0
--
csml-variable:Double
m19
0
infinite
0
--
csml-variable:Double
m20
0
infinite
0
--
--
e2
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m2
0
infinite
0
--
ISRE
--
e20
cso30:c:Dna
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m21
0
infinite
0
--
ISGF3: ISRE
--
e21
cso30:c:Complex
cso30:i:CC_Nucleoplasm
--
csml-variable:Double
m22
0
infinite
0
--
csml-variable:Double
m23
0
infinite
0
--
DRAF1
--
e25
cso30:c:Complex
cso30:i:CC_NuclearChromosome
--
csml-variable:Double
m26
0
infinite
0
--
IRF-7: IRF-7 {p}
--
e26
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m27
0
infinite
0
--
IRF-3{p}: IRF-7{p}
--
e27
cso30:c:Complex
cso30:i:CC_Cytosol
--
csml-variable:Double
m28
0
infinite
0
--
csml-variable:Double
m29
10
infinite
0
--
csml-variable:Double
m30
10
infinite
0
Affymetrix | 1418930_at |
Ensembl | ENSMUSG00000034855 |
MGD | Cxcl10 |
Proteome | HumanPSD/Cxcl10 |
RefSeq | NM_021274 |
TRANSFAC | G001062 |
Unigene | Mm.263514 |
--
--
e3
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_IntegralToPlasmaMembrane_
--
--
--
csml-variable:Double
m3
0
infinite
0
--
csml-variable:Double
m31
10
infinite
0
Affymetrix | 116778_at |
Ensembl | ENSMUSG00000024079 |
MGD | Eif2ak2 |
Proteome | HumanPSD/Eif2ak2 |
RefSeq | NM_011163 |
TRANSFAC | G001168 |
Unigene | Mm.378990 |
--
--
e4
cso30:c:EntityBiologicalCompartment
cso30:i:CC_PlasmaMembrane_InternalSideOfPlasmaMembrane_
--
--
--
csml-variable:Double
m4
0
infinite
0
--
IFN-alpha
--
e5
cso30:c:mRNA
cso30:i:CC_CellComponent
--
csml-variable:Double
m5
10
infinite
0
TRANSPATH | G016992 |
--
--
e50
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelopeLumen
--
--
--
csml-variable:Double
m50
0
infinite
0
--
--
e51
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearPore
--
--
--
csml-variable:Double
m51
0
infinite
0
--
--
e52
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearInnerMembrane
--
--
--
csml-variable:Double
m52
0
infinite
0
--
--
e53
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearLumen
--
--
--
csml-variable:Double
m53
0
infinite
0
--
--
e54
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearOuterMembrane
--
--
--
csml-variable:Double
m54
0
infinite
0
--
--
e55
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleus
--
--
--
csml-variable:Double
m55
0
infinite
0
--
--
e56
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleoplasm
--
--
--
csml-variable:Double
m56
0
infinite
0
--
--
e57
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearBody
--
--
--
csml-variable:Double
m57
0
infinite
0
--
--
e58
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Nucleolus
--
--
--
csml-variable:Double
m58
0
infinite
0
--
--
e59
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearEnvelope
--
--
--
csml-variable:Double
m59
0
infinite
0
--
AAF {nucleus}
--
e6
cso30:c:Protein
cso30:i:CC_Cytosol
--
csml-variable:Double
m6
0
infinite
0
--
--
e60
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Chromatin
--
--
--
csml-variable:Double
m60
0
infinite
0
--
--
e61
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearChromosome
--
--
--
csml-variable:Double
m61
0
infinite
0
--
--
e62
cso30:c:EntityBiologicalCompartment
cso30:i:CC_NuclearCentromere
--
--
--
csml-variable:Double
m62
0
infinite
0
--
--
e7
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell
--
--
--
csml-variable:Double
m7
0
infinite
0
--
--
e8
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cell_WithoutCellWall_
--
--
--
csml-variable:Double
m8
0
infinite
0
--
--
e9
cso30:c:EntityBiologicalCompartment
cso30:i:CC_Cytoplasm
--
--
--
csml-variable:Double
m9
0
infinite
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c1 : 1
stoichiometry:c2 : 1
stoichiometry:c3 : 1
m15*m16692*0.1
nodelay
--
0
PMID: 11790540, 11355893 In turn, virally induced IFN-alpha/beta activates Jak protein tyrosine kinases (Jak1 and Tyk2), leading to formation of both the ISGF3 transcriptional complex and AAF: the former activates several IFN-inducible genes including IRF-7 [39], whereas the latter mediates activation of the IRF-1 gene by its binding to GAS (IFN-gamma-activated site).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c27 : 1
stoichiometry:c28 : 1
m23*0.1
nodelay
--
0
PMID: 11790540 IRF-1 in turn induces genes such as that for iNOS.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c41 : 1
stoichiometry:c40 : 1
m26*0.1
nodelay
--
0
PMID: 11790540, 9707562, 9566918, 9541017 This phosphorylated IRF-3 then undergoes nuclear translocation, interacts with coactivators CBP and p300, and primarily activates the IFN-beta promoter. PMID: 11790540, 3805784, 6802744 In this context, it is interesting to note that IFN-alpha/beta are also induced by nonviral, pathogen-associated molecules, such as lipopolysaccharide (LPS) and unmethylated DNA.
p12
p12
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c42 : 1
stoichiometry:c46 : 1
stoichiometry:c43 : 1
m980*m119368*0.1
nodelay
--
0
PMID: 11790540, 9822609, 9877175, 9786932 Subsequently the de novo produced IRF-7 undergoes virus-induced phosphorylation, similar to IRF-3, and activates the IFN-alpha/beta promoters.
p13
p13
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c29 : 1
stoichiometry:c30 : 1
stoichiometry:c31 : 1
m155666*m977*0.1
nodelay
--
0
PMID: 11790540, 7559546, 9488451 Briefly, viral infections result in phosphorylation of the constitutively expressed IRF-3 at its carboxy-terminal region, converting it to its active form. PMID: 11790540, 3805784, 6802744 In this context, it is interesting to note that IFN-alpha/beta are also induced by nonviral, pathogen-associated molecules, such as lipopolysaccharide (LPS) and unmethylated DNA.
p14
p14
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c32 : 1
stoichiometry:c34 : 1
stoichiometry:c33 : 1
m977*m119368*0.1
nodelay
--
0
PMID: 11790540, 7559546, 9488451 Briefly, viral infections result in phosphorylation of the constitutively expressed IRF-3 at its carboxy-terminal region, converting it to its active form. PMID: 11790540, 7559546, 9488451 In fact, IRF-3 interacts with the CREB-binding protein (CBP)/p300 coativators, forming a complex, termed double-stranded RNA-activated factor 1 (DRAF1), for some IFN-inducible genes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c35 : 1
stoichiometry:c36 : 1
m19324*0.1
nodelay
--
0
PMID: 11790540, 9707562, 9566918, 9541017 This phosphorylated IRF-3 then undergoes nuclear translocation, interacts with coactivators CBP and p300, and primarily activates the IFN-beta promoter.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c37 : 1
stoichiometry:c38 : 1
stoichiometry:c39 : 1
m24*m25*0.1
nodelay
--
0
PMID: 11790540, 9707562, 9566918, 9541017 This phosphorylated IRF-3 then undergoes nuclear translocation, interacts with coactivators CBP and p300, and primarily activates the IFN-beta promoter. PMID: 11790540, 7559546, 9488451 In fact, IRF-3 interacts with the CREB-binding protein (CBP)/p300 coativators, forming a complex, termed double-stranded RNA-activated factor 1 (DRAF1), for some IFN-inducible genes.
p17
p17
cso30:i:ME_Phosphorylation
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c44 : 1
stoichiometry:c47 : 1
stoichiometry:c45 : 1
m980*m155666*0.1
nodelay
--
0
PMID: 11790540, 9822609, 9877175, 9786932 Subsequently the de novo produced IRF-7 undergoes virus-induced phosphorylation, similar to IRF-3, and activates the IFN-alpha/beta promoters. PMID: 11790540, 3805784, 6802744 In this context, it is interesting to note that IFN-alpha/beta are also induced by nonviral, pathogen-associated molecules, such as lipopolysaccharide (LPS) and unmethylated DNA.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c48 : 1
stoichiometry:c50 : 1
m27*0.1
nodelay
--
0
PMID: 11790540, 9822609, 9877175, 9786932 Subsequently the de novo produced IRF-7 undergoes virus-induced phosphorylation, similar to IRF-3, and activates the IFN-alpha/beta promoters. PMID: 11790540, 11318879 In the absence of the other, IRF-3 acts on the IFN-beta gene, whereas IRF-7 acts on both IFN-alpha and IFN-beta genes by forming homodimers, and both IRF-3 and IRF-7 are required, functioning as a heterodimer, for amplifying the induction of IFN-beta and certain IFN-alpha family genes. PMID: 11790540, 3805784, 6802744 In this context, it is interesting to note that IFN-alpha/beta are also induced by nonviral, pathogen-associated molecules, such as lipopolysaccharide (LPS) and unmethylated DNA.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c49 : 1
stoichiometry:c51 : 1
m27*0.1
nodelay
--
0
PMID: 11790540, 9822609, 9877175, 9786932 Subsequently the de novo produced IRF-7 undergoes virus-induced phosphorylation, similar to IRF-3, and activates the IFN-alpha/beta promoters. PMID: 11790540, 11318879 In the absence of the other, IRF-3 acts on the IFN-beta gene, whereas IRF-7 acts on both IFN-alpha and IFN-beta genes by forming homodimers, and both IRF-3 and IRF-7 are required, functioning as a heterodimer, for amplifying the induction of IFN-beta and certain IFN-alpha family genes. PMID: 11790540, 3805784, 6802744 In this context, it is interesting to note that IFN-alpha/beta are also induced by nonviral, pathogen-associated molecules, such as lipopolysaccharide (LPS) and unmethylated DNA.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c4 : 1
stoichiometry:c5 : 1
m16*0.1
nodelay
--
0
PMID: 11790540, 11355893 In turn, virally induced IFN-alpha/beta activates Jak protein tyrosine kinases (Jak1 and Tyk2), leading to formation of both the ISGF3 transcriptional complex and AAF: the former activates several IFN-inducible genes including IRF-7 [39], whereas the latter mediates activation of the IRF-1 gene by its binding to GAS (IFN-gamma-activated site).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c52 : 1
stoichiometry:c53 : 1
m19325*0.1
nodelay
--
0
PMID: 11790540, 11318879 In the absence of the other, IRF-3 acts on the IFN-beta gene, whereas IRF-7 acts on both IFN-alpha and IFN-beta genes by forming homodimers, and both IRF-3 and IRF-7 are required, functioning as a heterodimer, for amplifying the induction of IFN-beta and certain IFN-alpha family genes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c56 : 1
stoichiometry:c55 : 1
m28*0.1
nodelay
--
0
PMID: 11790540, 11318879 In the absence of the other, IRF-3 acts on the IFN-beta gene, whereas IRF-7 acts on both IFN-alpha and IFN-beta genes by forming homodimers, and both IRF-3 and IRF-7 are required, functioning as a heterodimer, for amplifying the induction of IFN-beta and certain IFN-alpha family genes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c57 : 1
stoichiometry:c54 : 1
m28*0.1
nodelay
--
0
PMID: 11790540, 11318879 In the absence of the other, IRF-3 acts on the IFN-beta gene, whereas IRF-7 acts on both IFN-alpha and IFN-beta genes by forming homodimers, and both IRF-3 and IRF-7 are required, functioning as a heterodimer, for amplifying the induction of IFN-beta and certain IFN-alpha family genes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c60 : 1
stoichiometry:c59 : 1
m11*0.1
nodelay
--
0
PMID: 11790540, 3805784, 6802744 In this context, it is interesting to note that IFN-alpha/beta are also induced by nonviral, pathogen-associated molecules, such as lipopolysaccharide (LPS) and unmethylated DNA.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c61 : 1
stoichiometry:c58 : 1
m11*0.1
nodelay
--
0
PMID: 11790540, 3805784, 6802744 In this context, it is interesting to note that IFN-alpha/beta are also induced by nonviral, pathogen-associated molecules, such as lipopolysaccharide (LPS) and unmethylated DNA.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c62 : 1
stoichiometry:c64 : 1
m26*0.1
nodelay
--
0
PMID: 11790540 More recently, genetic evidence has indicated that some IFN-inducible genes, such as ISG15 and IP-10, are indeed activated in virally infected cells in the absence of ISGF3 by a mechanism dependent on IRF-3 (in the context of the DRAF1 complex) but not on IRF-7.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c63 : 1
stoichiometry:c65 : 1
m26*0.1
nodelay
--
0
PMID: 11790540 More recently, genetic evidence has indicated that some IFN-inducible genes, such as ISG15 and IP-10, are indeed activated in virally infected cells in the absence of ISGF3 by a mechanism dependent on IRF-3 (in the context of the DRAF1 complex) but not on IRF-7.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c66 : 1
stoichiometry:c68 : 1
m22*0.1
nodelay
--
0
PMID: 11790540 Moreover, these genes are also activated by ISGF3 in the absence of IRF-3.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c67 : 1
stoichiometry:c69 : 1
m22*0.1
nodelay
--
0
PMID: 11790540 Moreover, these genes are also activated by ISGF3 in the absence of IRF-3.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c70 : 1
stoichiometry:c71 : 1
m22*0.1
nodelay
--
0
PMID: 11790540, 11355893 By contrast, the induction of other genes, such as 2¡ì-5¡ì oligoadenylate synthetase (OAS) and double-stranded-RNA-dependent protein kinase (PKR) is totally dependent on ISGF3, which cannot directly activate the IFN-alpha/beta genes.
p3
p3
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c6 : 1
stoichiometry:c7 : 1
stoichiometry:c8 : 1
stoichiometry:c10 : 1
stoichiometry:c9 : 1
m1357*m1358*m12*m18*0.1
nodelay
--
0
PMID: 11790540 The IFN-alpha/beta stimulation of the homologous receptor complex, termed IFNAR, leads to the formation of two transcriptional activator complexes: IFN-alpha-activated factor (AAF), which is a homodimer of signal transducer and activator of transcription (Stat)1; and IFN-stimulated gene factor 3 (ISGF3), which comprises Stat1, Stat2 and a member of the IRF family, IRF-9 (also known as p48).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c73 : 1
stoichiometry:c72 : 1
m22*0.1
nodelay
--
0
PMID: 11790540, 11355893 By contrast, the induction of other genes, such as 2¡ì-5¡ì oligoadenylate synthetase (OAS) and double-stranded-RNA-dependent protein kinase (PKR) is totally dependent on ISGF3, which cannot directly activate the IFN-alpha/beta genes.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c74 : 1
stoichiometry:c75 : 1
m1636*0.1
nodelay
--
0
PMID: 11790540, 10875919, 9501984 In fibroblasts, IFN-alpha/beta expression is observed even after serum starvation, and IFN-alpha expression in these cells is dependent on IFN-beta for an as-yet-unknown reason.
p32
p32
cso30:i:ME_Binding
cso30:i:CC_PlasmaMembrane_ExternalSideOfPlasmaMembrane_
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c76 : 1
stoichiometry:c77 : 1
stoichiometry:c78 : 1
m3258*m3373*0.1
nodelay
--
0
PMID: 11790540 More recently, we found that the IFN-beta gene is induced in bone marrow macrophages upon stimulation by RANK ligand (receptor activator of NF-kappaB ligand) as a negative regulator of osteoclast differentiation, and that this induction is not dependent on IRFs but on RANKL-induced c-Fos, one of the essential transcriptional factors for osteoclast differentiation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c79 : 1
stoichiometry:c80 : 1
m32*0.1
nodelay
--
0
PMID: 11790540 More recently, we found that the IFN-beta gene is induced in bone marrow macrophages upon stimulation by RANK ligand (receptor activator of NF-kappaB ligand) as a negative regulator of osteoclast differentiation, and that this induction is not dependent on IRFs but on RANKL-induced c-Fos, one of the essential transcriptional factors for osteoclast differentiation.
p34
p34
cso30:i:ME_GeneExpression
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c83 : 1
stoichiometry:c84 : 1
m221*0.1
nodelay
--
0
PMID: 11790540 More recently, we found that the IFN-beta gene is induced in bone marrow macrophages upon stimulation by RANK ligand (receptor activator of NF-kappaB ligand) as a negative regulator of osteoclast differentiation, and that this induction is not dependent on IRFs but on RANKL-induced c-Fos, one of the essential transcriptional factors for osteoclast differentiation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c82 : 1
stoichiometry:c81 : 1
m93203*0.1
nodelay
--
0
PMID: 11790540 More recently, we found that the IFN-beta gene is induced in bone marrow macrophages upon stimulation by RANK ligand (receptor activator of NF-kappaB ligand) as a negative regulator of osteoclast differentiation, and that this induction is not dependent on IRFs but on RANKL-induced c-Fos, one of the essential transcriptional factors for osteoclast differentiation.
p36
p36
cso30:i:ME_GeneExpression
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c86 : 1
stoichiometry:c85 : 1
m14*0.1
nodelay
--
0
PMID: 11790540, 9541017, 9660935, 9446577 We also speculate that IFN-beta represents the prototype IFN gene, which is subject to induction by a various factors such as IRF-3, c-Fos and NF-kappaB.
p37
p37
cso30:i:CE_CellDifferentiation
cso30:i:CC_Extracellular
--
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c87 : 1
stoichiometry:c88 : 1
m221*0.1
nodelay
--
0
PMID: 11790540 More recently, we found that the IFN-beta gene is induced in bone marrow macrophages upon stimulation by RANK ligand (receptor activator of NF-kappaB ligand) as a negative regulator of osteoclast differentiation, and that this induction is not dependent on IRFs but on RANKL-induced c-Fos, one of the essential transcriptional factors for osteoclast differentiation.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c14 : 1
stoichiometry:c89 : 1
m17*0.1
nodelay
--
0
PMID: 11790540 The latter mediates activation of the IRF-1 gene by its binding to GAS (IFN-gamma-activated site).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c21 : 1
stoichiometry:c91 : 1
m13*0.1
nodelay
--
0
PMID: 11790540, 8197455 ISGF3 binds to cis elements, termed IFN-stimulated response elements (ISREs; consensus sequence A/GNGAAANNGAAACT), which usually reside within the promoter region of IFN-inducible genes [5].
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c11 : 1
stoichiometry:c13 : 1
stoichiometry:c12 : 1
m1357*m18*0.1
nodelay
--
0
PMID: 11790540 The IFN-alpha/beta stimulation of the homologous receptor complex, termed IFNAR, leads to the formation of two transcriptional activator complexes: IFN-alpha-activated factor (AAF), which is a homodimer of signal transducer and activator of transcription (Stat)1; and IFN-stimulated gene factor 3 (ISGF3), which comprises Stat1, Stat2 and a member of the IRF family, IRF-9 (also known as p48).
p40
p40
cso30:i:ME_Binding
cso30:i:CC_Cytosol
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c93 : 1
stoichiometry:c94 : 1
stoichiometry:c95 : 1
m19324*m19325*0.1
nodelay
--
0
--
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c15 : 1
stoichiometry:c90 : 1
stoichiometry:c16 : 1
m20*m6*0.1
nodelay
--
0
PMID: 11790540 The latter mediates activation of the IRF-1 gene by its binding to GAS (IFN-gamma-activated site).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c17 : 1
stoichiometry:c18 : 1
m19*0.1
nodelay
--
0
PMID: 11790540 The latter mediates activation of the IRF-1 gene by its binding to GAS (IFN-gamma-activated site).
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c19 : 1
stoichiometry:c92 : 1
stoichiometry:c20 : 1
m21*m33*0.1
nodelay
--
0
PMID: 11790540, 8197455 ISGF3 binds to cis elements, termed IFN-stimulated response elements (ISREs; consensus sequence A/GNGAAANNGAAACT), which usually reside within the promoter region of IFN-inducible genes [5].
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c23 : 1
stoichiometry:c22 : 1
m22*0.1
nodelay
--
0
PMID: 11790540, 11355893 The former activates several IFN-inducible genes including IRF-7.
--
and
mass
coefficient1:0.1
coefficient2:1.0
stoichiometry:c24 : 1
stoichiometry:c25 : 1
stoichiometry:c26 : 1
m970*m21*0.1
nodelay
--
0
PMID: 11790540, 2342456, 7687740 ISREs are also known to bind and be activated by IRF-1.
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:InputAssociation
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--
cso30:c:InputProcess
threshold
--
0
1,
--
cso30:c:OutputProcess
threshold
--
0
1,
--